Recent treatment advances in Hodgkin lymphoma: a concise review.


The majority of patients with Hodgkin lymphoma enjoy durable remissions following front-line treatment. This typically involves combination chemotherapy with or without radiotherapy. A significant minority of patients experience relapsed/refractory disease, of whom only approximately half can be 'salvaged' with conventional second-line treatments. Until… (More)
DOI: 10.1111/imj.13051


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics